FDA Consumer

View more issues:

Articles in Nov, 1996 issue of FDA Consumer

• Drug for testing HIV wasting gets early approval - the FDA approved the injectable drug Serostim on Aug 23, 1996; it is distributed by Serono Laboratories Inc - Updates - Brief Article
• Agency changes include medical device review - Inside FDA
  by Dixie Farley
• Now available without a prescription - FDA makes more drugs over-the-counter - includes related articles on Nicotrol and Rogaine
  by Tamar Nordenberg
• Women's incontinence product - the FDA approved UroMed Corp.'s Reliance Urinary Control Insert Device on Aug 16, 1996 - Updates - Brief Article
• Rabies on the rise - includes related articles on transmission and prevention - Cover Story
  by Audrey T. Hingley
• Lung cancer imaging agent - on Aug 20, 1996, the FDA approved the agent Nofetumomab, trade name Verluma, for use in detecting the extent of small cell lung cancer - Updates - Brief Article
• HIV-related use for antibiotic - in Jun 1996, the FDA approved the drug Zithromax for use in HIV-patients suffering from mycobacterium avium complex - Updates - Brief Article
• Promoter of 714x cure-all faces prison for selling unapproved drug - Charles Pixley - Investigators' Reports
  by Paula Kurtzweil
• Adrenal cortex extract alert - the FDA warns consumers that the extract can cause abscesses and other serious health problems; the vials are marketed under the Hallmark Labs label - Updates - Brief Article
• Decreasing the chance of birth defects: most birth defects occur in the first three months of pregnancy, when the organs are forming - includes related article on Accutane
  by Rebecca Williams
• First drug to protect against poison ivy - the FDA approved Enviroderm's non-prescription ointment Ivy Block, which should be applied before exposure - Updates - Brief Article
• Controlling asthma
  by Ken Flieger
• FDA warning concerning certain Italian cheese - imported Italian mascarpone cream cheese produced by Giglio may be contaminated with botulism - Updates - Brief Article
• Lights out on illegal laser light show - Investigators' Reports
  by Tamar Nordenberg
• Redux relabeling notes higher risk - Interneuron Pharmaceuticals and distributor Wyeth-Ayerst agreed to put new labels on Redux, warning of risk of primary pulmonary hypertension - Updates - Brief Article
• Calf company cleans up act - D & S Calf Co - Investigators' Reports
  by Isadora B. Stehlin